Navigation Links
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
Date:10/30/2013

SAN DIEGO, Oct. 30, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it will provide a corporate update and report third quarter 2013 financial results after the NASDAQ Global Select Market closes on Thursday, November 7, 2013. That same day, Arena will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Third Quarter 2013 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena PharmaceuticalsArena is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ® (lorcaserin HCl), Arena's internally discovered drug, is approved in the United States and is under review for regulatory approval in additional territories. Arena's US operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland. For more information, visit Arena's website at www.arenapharm.com.

Arena Pharmaceuticals® and Arena
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
11. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 15, 2014   DaVita ... one of the nation,s largest and most innovative ... its business units, DaVita Clinical Research  (DCR) and  ... to further expand its extensive clinical research and ... kidney disease (CKD) and end-stage renal disease (ESRD), ...
(Date:12/13/2014)... DUBLIN , Dec. 11, 2014 Research ... announced the addition of the "Drug Injection ... http://photos.prnewswire.com/prnh/20130307/600769 ... treatment of an expanding list of health conditions, ... options that simplify the administration process and increase ...
(Date:12/13/2014)... Mindray Medical International Limited ("Mindray", NYSE: ... of medical devices worldwide, today announced shareholder resolutions adopted ... Hong Kong on December 10, ... to re-elect incumbent directors Li Xiting and Kern Lim, ... not re-elect Peter Wan as a director. ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... , , , , ... and development company, announced today that it has closed a $6.5M Series ... technology for CM-AT for autism. Phase III clinical trials are about to ... "The Series A funding will allow us to complete our clinical trials ...
... , LOS ANGELES, Aug. 7 A new ... any drug and sealed to the outer surface (episclera) of the ... of medicines for retinal and vitreous diseases, according to a new ... in The Vision Center at Children,s Hospital Los Angeles. Dr. Murphree ...
Cached Medicine Technology:Curemark Closes Series A Financing 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 3Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... been successfully treated for their disease face the ... testicular) tissue is transplanted back into their bodies ... university hospitals in Israel. , Writing in Europes ... 22 April), the researchers say that hundreds of ...
... ,biological mechanism, that leads to adverse reactions identified, officials ... heparin products have now been found in at least ... ongoing surveillance measures to ensure the safety of the ... addition, officials said contaminated lots of the blood thinner ...
... stories of suffering from trauma victims causes serious psychological ... suggests. , In a study appearing in the May ... Investigator Joseph Boscarino, PhD, MPH and his co-researchers examined ... New York City social workers following the Sept. 11 ...
... highlights:, -- Record quarterly net sales of $668.2 million, up 13.4% year over year and ... share, up 12.5% over the same period last year, -- Record quarterly Catalysts segment income of $51.7 million resulting ... ... First Quarter ...
... OMCL ), a leading provider of system solutions ... quarter ended,March 31, 2008., GAAP results: Revenues for ... million or 7.2% from the fourth quarter of 2007 ... of 2007., First quarter 2008 net income as ...
... ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced ... 30, 2008, after the U.S. markets,close. ISTA will host ... results at 4:30 p.m. Eastern Time on April 30., ... Canadian participants may,dial 866-362-5158; international participants may dial 617-597-5397. ...
Cached Medicine News:Health News:Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation 2Health News:Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation 3Health News:FDA: Contaminated Heparin Found in 10 Countries 2Health News:FDA: Contaminated Heparin Found in 10 Countries 3Health News:FDA: Contaminated Heparin Found in 10 Countries 4Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 2Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 3Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 4Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 5Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 6Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 7Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 8Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 9Health News:Albemarle Reports Record Quarterly Net Sales and Operating Results 10Health News:Omnicell Announces First Quarter 2008 Results 2Health News:Omnicell Announces First Quarter 2008 Results 3Health News:Omnicell Announces First Quarter 2008 Results 4Health News:Omnicell Announces First Quarter 2008 Results 5Health News:Omnicell Announces First Quarter 2008 Results 6Health News:Omnicell Announces First Quarter 2008 Results 7Health News:Omnicell Announces First Quarter 2008 Results 8Health News:Omnicell Announces First Quarter 2008 Results 9Health News:Omnicell Announces First Quarter 2008 Results 10Health News:Omnicell Announces First Quarter 2008 Results 11
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... Tendril SDX model 1688 and model 1488 ... extendable/retractable pacing leads, offering the unsurpassed handling ... Jude Medical's line of active-fixation leads. Implantable ... body diameter of the Tendril SDX lead ...
... battery-backed up, microprocessor based, quality instrument that monitors ... and displays a chart on its large panel ... or zoomed into and out of, so that ... months can be seen at one time. ...
... Aegis CheckPoint is an automated, wireless, ... and alert system for refrigerator, freezer, ... chart recorders, data loggers and manual ... on an existing PC and comes ...
Medicine Products: